Aperio Group’s Inovio Pharmaceuticals INO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | $280K | Sell |
2,633
-17
| -0.6% | -$1.81K | ﹤0.01% | 2211 |
|
|
2020
Q3 | $369K | Buy |
2,650
+155
| +6% | +$21.6K | ﹤0.01% | 1975 |
|
|
2020
Q2 | $807K | Sell |
2,495
-324
| -11% | -$105K | ﹤0.01% | 1515 |
|
|
2020
Q1 | $252K | Buy |
+2,819
| New | +$252K | ﹤0.01% | 1999 |
|
|
2019
Q3 | – | Sell |
-486
| Closed | -$17K | – | 2524 |
|
|
2019
Q2 | $17K | Sell |
486
-720
| -60% | -$25.2K | ﹤0.01% | 2709 |
|
|
2019
Q1 | $54K | Buy |
1,206
+180
| +18% | +$8.06K | ﹤0.01% | 2267 |
|
|
2018
Q4 | $49K | Sell |
1,026
-16
| -2% | -$764 | ﹤0.01% | 2260 |
|
|
2018
Q3 | $69K | Sell |
1,042
-93
| -8% | -$6.16K | ﹤0.01% | 2266 |
|
|
2018
Q2 | $53K | Buy |
1,135
+47
| +4% | +$2.2K | ﹤0.01% | 2245 |
|
|
2018
Q1 | $62K | Buy |
+1,088
| New | +$62K | ﹤0.01% | 2230 |
|